Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,425.38
(
0.13%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: Bio_pete post# 138364

Wednesday, 03/07/2012 3:38:14 PM

Wednesday, March 07, 2012 3:38:14 PM

Post# of 257300
Teva thrice-weekly Copaxone formulation

I don't see why TEVA needs to wait for the extension study to complete prior to filing for approval. Couldn't they file & then submit the extension study data as an addendum?

I don't think TEVA needs to wait for the extension study to complete. If data are ok (and they should be), I think we'll see filing in early 2013.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today